Prelude is a technology company building a better hiring process. We’re improving interviewing by removing friction, increasing transparency, and creating more joy. We help candidates and teams see the best in each other.
Location: France
Employees: 11-50
Total raised: $20M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | FUEL Capit... | fuelcapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.05.2026 | Series A | $20M | Seedcamp |
Mentions in press and media 13
| Date | Title | Description |
| 22.05.2026 | Prelude: $20 Million Series A Raised To Build The Onboarding And Trust Layer For The AI Age | Prelude, a company building onboarding and trust infrastructure for the AI era, announced it has raised $20 million in Series A funding led by 20VC, with participation from existing investors Singular, Seedcamp, Deel, and FDJ UNITED Venture... |
| 27.09.2022 | Calendly, the $3B+ scheduling startup, acquires Prelude to drive into the recruitment sector | Calendly, the scheduling startup that landed with a splash last year when it raised a huge round out of nowhere at a $3 billion+ valuation, has made a name for itself for tools that are used by more than 10 million people to book appointmen... |
| 29.06.2021 | In many an IPO, Apple’s App Store gets the “catastrophic events” treatment | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Workday’s secret to success? Adaptability and flexibility From Workday Few education... |
| 29.06.2021 | In many an IPO, Apple’s App Store gets the “catastrophic events” treatment | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Why today's marketers need strong collaboration tools From Optimizely Few education ... |
| 29.06.2021 | Daily funding roundup - June 29th, 2021 | Outdoorsy raised $90M; Side landed $50M; LocoNav secured $37M; Hospital IQ landed $25M Outdoorsy: Outdoorsy is a Austin, Tex.-based on-demand marketplace for recreational vehicles. Outdoorsy has raised $90 million in fresh funding from Moor... |
| 24.08.2020 | Prelude Therapeutics Raises $50M In Series C | WILMINGTON, Del.--(BUSINESS WIRE)--Prelude Therapeutics, a privately-held, clinical-stage precision oncology company, today announced that it has completed a $50 million Series C financing round led by Prelude’s two existing institutional i... |
| 19.06.2019 | Prelude Therapeutics Closes $60 Million To Develop Drugs Targeting Drivers Of Cancer Cell Growth | Wilmington, Delaware-based clinical-stage biopharmaceutical company Prelude Therapeutics has raised $60 million in funding Prelude Therapeutics, a Wilmington, Delaware-based clinical-stage biopharmaceutical company that focuses on the disco... |
| 12.06.2019 | Prelude Therapeutics nabs $60M series B, gains biopharma veteran as CMO W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Prelude Therapeutics has completed a $60 million series B round, boosting its total raised to $95 million as it looks to deepen its cancer work into the clinic. Sponsored by Agilent Technologies How would you like to win free bench space at... |
| 12.06.2019 | Prelude Therapeutics Secures $60 Million | WILMINGTON, Del.--(BUSINESS WIRE)--Prelude Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the discovery and development of small molecule drugs that target key drivers of cancer cell growth, survival and... |
| 12.06.2019 | Prelude Therapeutics raises $60M in Series B round for solid tumor, blood cancer drug | The company plans to use the money to advance its lead product candidate, PRT543, through clinical proof-of-concept studies. The drug is in a Phase I study at three centers for solid tumors, myeloid malignancies and lymphomas. According to ... |
Show more